Link
Critical Evidence Questions For COVID-19 Vaccines Policy Making
Organization: World Health Organization (WHO)Published: 2020
"This document lists areas of evidence that would assist SAGE to formulate policy recommendations for consideration by WHO regarding the use of COVID-19 vaccines as they become available. It is not intended as alternative to the lists of requirements for licensure as formulated by regulatory bodies nor does it replace or provide an alternative to the WHO Target Product Profile. Rather it reflects the evidence-needs for COVID-19 vaccine policy making, based on the current scientific thinking, to assist SAGE in deciding upon the optimal use given the limited vaccine supply in order to maximise impact on the pandemic in different populations and epidemiologic settings." - Critical Evidence Questions For COVID-19 Vaccines Policy Making
Product Type: Guide
Category:
Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Policy,Immunization Policies,Evaluations Monitoring and SurveillanceOutbreaks and Pandemics
COVID-19
Policy
Immunization Policies
Evaluations
Policy Makers
Population: Children (All)
Adults
Seniors
Healthcare Personnel
Region: International
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.